New Mexico Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.

Press releases published on October 2, 2026

6 hours ago

SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals

Indeterminate GlobeNewswire

6 hours ago

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

Indeterminate GlobeNewswire

6 hours ago

Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients

Indeterminate GlobeNewswire

6 hours ago

Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome

Indeterminate GlobeNewswire

6 hours ago

Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization

Indeterminate GlobeNewswire

6 hours ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Celcuity Appoints David Gryska To Its Board Of Directors

Indeterminate GlobeNewswire

6 hours ago

Persephone Biosciences to Provide 50,000 Free Doses of Groundbreaking Infant and Toddler Synbiotics

Indeterminate GlobeNewswire

6 hours ago

Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

Indeterminate GlobeNewswire

6 hours ago

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Indeterminate GlobeNewswire

6 hours ago

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire

6 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

Indeterminate GlobeNewswire

7 hours ago

Published Human Research Gives Family Caregivers a Way to Evaluate Joint Supplements

Indeterminate GlobeNewswire

7 hours ago

Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week

Indeterminate GlobeNewswire

7 hours ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

7 hours ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

7 hours ago

Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering

Indeterminate GlobeNewswire